Insider Trading activities of Aveo Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aveo Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aveo Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Aveo Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is AVEO. The reporting company's CIK number is 1325879.
The total value of stock buying since 2005 is $57,023,215.
The total value of stock sales since 2005 is $16,331,785.
The total value of stock option exercises since 2005 is $1,224,307.


 1   2 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Aveo Pharmaceuticals Inc (AVEO).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-05 1,893,875 $4,035,240 0 $0 0 $0
2018-04 9,209,760 $21,154,590 0 $0 0 $0
2017-03 60,000,000 $30,000,000 0 $0 0 $0
2015-01 0 $0 17,046 $13,688 0 $0
2014-01 0 $0 21,720 $35,704 0 $0
2013-03 55,499 $373,730 1,061 $7,784 0 $0
2013-02 990 $6,533 0 $0 0 $0
2013-01 0 $0 5,368 $41,712 0 $0
2012-12 138,122 $916,984 0 $0 0 $0
2012-09 0 $0 1,386 $14,695 37,500 $75,000
2012-08 1,000 $8,630 0 $0 0 $0
2012-07 0 $0 3,000 $39,332 3,000 $28,920
2012-06 0 $0 17,000 $208,150 17,000 $103,280
2012-05 0 $0 5,000 $63,921 2,000 $19,280
2012-04 0 $0 1,000 $12,377 1,000 $9,640
2012-03 0 $0 8,100 $106,426 0 $0
2012-02 5,000 $69,340 6,000 $80,859 52,000 $43,280
2012-01 0 $0 11,410 $155,509 2,000 $19,280
2011-12 0 $0 8,000 $132,107 8,000 $73,080
2011-11 0 $0 5,000 $78,038 5,000 $40,120
2011-10 0 $0 7,000 $112,595 7,000 $59,400
2011-09 0 $0 7,000 $117,358 7,000 $59,400
2011-08 0 $0 11,267 $182,972 11,500 $96,560
2011-07 0 $0 13,800 $280,529 13,800 $79,552
2011-06 0 $0 22,200 $408,971 12,200 $64,128
2011-05 0 $0 187,700 $3,311,236 17,700 $88,880
2011-04 0 $0 56,300 $836,063 6,300 $35,520
2011-03 15,000 $216,555 10,500 $150,733 3,000 $28,920
2011-02 0 $0 8,000 $113,793 8,000 $35,520
2011-01 0 $0 15,400 $226,348 84,050 $140,247
2010-12 0 $0 633,008 $9,326,063 9,500 $29,180
2010-11 0 $0 10,000 $163,874 5,000 $48,200
2010-10 0 $0 8,000 $110,948 3,000 $28,920
2010-05 2,408 $18,613 0 $0 0 $0
2010-03 25,000 $223,000 0 $0 37,500 $18,000

Table 2. Detailed insider stock purchases, sales, and option exercises of Aveo Pharmaceuticals Inc insiders (AVEO)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-05-30 New Enterprise Associates 15, L.p. (10% Owner) Buy 275 2.15 591
2018-05-30 Sakoda Jon (10% Owner) Buy 275 2.15 591
2018-05-30 Florence Anthony A. Jr. (10% Owner) Buy 275 2.15 591
2018-05-30 Sonsini Peter W. (10% Owner) Buy 275 2.15 591
2018-05-30 Viswanathan Ravi (10% Owner) Buy 275 2.15 591
2018-05-30 Baskett Forest (10% Owner) Buy 275 2.15 591
2018-05-30 Sandell Scott D (10% Owner) Buy 275 2.15 591
2018-05-30 Makower Joshua (10% Owner) Buy 275 2.15 591
2018-05-30 Mott David M (10% Owner) Buy 275 2.15 591
2018-05-30 Barris Peter J (10% Owner) Buy 275 2.15 591
2018-05-21 Sakoda Jon (10% Owner) Buy 32,200 2.15 69,069
2018-05-21 Sonsini Peter W. (10% Owner) Buy 32,200 2.15 69,069
2018-05-21 Viswanathan Ravi (10% Owner) Buy 32,200 2.15 69,069
2018-05-21 Sandell Scott D (10% Owner) Buy 32,200 2.15 69,069
2018-05-21 Mott David M (10% Owner) Buy 32,200 2.15 69,069
2018-05-18 Sakoda Jon (10% Owner) Buy 20,100 2.14 42,933
2018-05-18 Sonsini Peter W. (10% Owner) Buy 20,100 2.14 42,933
2018-05-18 Viswanathan Ravi (10% Owner) Buy 20,100 2.14 42,933
2018-05-18 Sandell Scott D (10% Owner) Buy 20,100 2.14 42,933
2018-05-18 Mott David M (10% Owner) Buy 20,100 2.14 42,933
2018-05-17 Sakoda Jon (10% Owner) Buy 184,179 2.12 391,380
2018-05-17 Sonsini Peter W. (10% Owner) Buy 184,179 2.12 391,380
2018-05-17 Viswanathan Ravi (10% Owner) Buy 184,179 2.12 391,380
2018-05-17 Sandell Scott D (10% Owner) Buy 184,179 2.12 391,380
2018-05-17 Mott David M (10% Owner) Buy 184,179 2.12 391,380
2018-05-08 New Enterprise Associates 15, L.p. (10% Owner) Buy 70,873 2.13 151,242
2018-05-08 Sakoda Jon (10% Owner) Buy 70,873 2.13 151,242
2018-05-08 Florence Anthony A. Jr. (10% Owner) Buy 70,873 2.13 151,242
2018-05-08 Sonsini Peter W. (10% Owner) Buy 70,873 2.13 151,242
2018-05-08 Viswanathan Ravi (10% Owner) Buy 70,873 2.13 151,242
2018-05-08 Baskett Forest (10% Owner) Buy 70,873 2.13 151,242
2018-05-08 Sandell Scott D (10% Owner) Buy 70,873 2.13 151,242
2018-05-08 Makower Joshua (10% Owner) Buy 70,873 2.13 151,242
2018-05-08 Mott David M (10% Owner) Buy 70,873 2.13 151,242
2018-05-08 Barris Peter J (10% Owner) Buy 70,873 2.13 151,242
2018-04-10 New Enterprise Associates 15, L.p. (10% Owner) Buy 203,200 2.46 500,075
2018-04-10 Sakoda Jon (10% Owner) Buy 203,200 2.46 500,075
2018-04-10 Florence Anthony A. Jr. (10% Owner) Buy 203,200 2.46 500,075
2018-04-10 Sonsini Peter W. (10% Owner) Buy 203,200 2.46 500,075
2018-04-10 Viswanathan Ravi (10% Owner) Buy 203,200 2.46 500,075
2018-04-10 Baskett Forest (10% Owner) Buy 203,200 2.46 500,075
2018-04-10 Sandell Scott D (10% Owner) Buy 203,200 2.46 500,075
2018-04-10 Makower Joshua (10% Owner) Buy 203,200 2.46 500,075
2018-04-10 Mott David M (10% Owner) Buy 203,200 2.46 500,075
2018-04-10 Barris Peter J (10% Owner) Buy 203,200 2.46 500,075
2018-04-09 New Enterprise Associates 15, L.p. (10% Owner) Buy 32,100 2.43 78,099
2018-04-09 Sakoda Jon (10% Owner) Buy 32,100 2.43 78,099
2018-04-09 Florence Anthony A. Jr. (10% Owner) Buy 32,100 2.43 78,099
2018-04-09 Sonsini Peter W. (10% Owner) Buy 32,100 2.43 78,099
2018-04-09 Viswanathan Ravi (10% Owner) Buy 32,100 2.43 78,099
2018-04-09 Baskett Forest (10% Owner) Buy 32,100 2.43 78,099
2018-04-09 Sandell Scott D (10% Owner) Buy 32,100 2.43 78,099
2018-04-09 Makower Joshua (10% Owner) Buy 32,100 2.43 78,099
2018-04-09 Mott David M (10% Owner) Buy 32,100 2.43 78,099
2018-04-09 Barris Peter J (10% Owner) Buy 32,100 2.43 78,099
2018-04-06 New Enterprise Associates 15, L.p. (10% Owner) Buy 685,676 2.24 1,537,285
2018-04-06 Sakoda Jon (10% Owner) Buy 685,676 2.24 1,537,285
2018-04-06 Florence Anthony A. Jr. (10% Owner) Buy 685,676 2.24 1,537,285
2018-04-06 Sonsini Peter W. (10% Owner) Buy 685,676 2.24 1,537,285
2018-04-06 Viswanathan Ravi (10% Owner) Buy 685,676 2.24 1,537,285
2018-04-06 Baskett Forest (10% Owner) Buy 685,676 2.24 1,537,285
2018-04-06 Sandell Scott D (10% Owner) Buy 685,676 2.24 1,537,285
2018-04-06 Makower Joshua (10% Owner) Buy 685,676 2.24 1,537,285
2018-04-06 Mott David M (10% Owner) Buy 685,676 2.24 1,537,285
2018-04-06 Barris Peter J (10% Owner) Buy 685,676 2.24 1,537,285
2017-03-28 New Enterprise Associates 15, L.p. (10% Owner) Buy 6,000,000 .50 3,000,000
2017-03-28 Sakoda Jon (10% Owner) Buy 6,000,000 .50 3,000,000
2017-03-28 Florence Anthony A. Jr. (10% Owner) Buy 6,000,000 .50 3,000,000
2017-03-28 Sonsini Peter W. (10% Owner) Buy 6,000,000 .50 3,000,000
2017-03-28 Viswanathan Ravi (10% Owner) Buy 6,000,000 .50 3,000,000
2017-03-28 Baskett Forest (10% Owner) Buy 6,000,000 .50 3,000,000
2017-03-28 Sandell Scott D (10% Owner) Buy 6,000,000 .50 3,000,000
2017-03-28 Makower Joshua (10% Owner) Buy 6,000,000 .50 3,000,000
2017-03-28 Mott David M (10% Owner) Buy 6,000,000 .50 3,000,000
2017-03-28 Barris Peter J (10% Owner) Buy 6,000,000 .50 3,000,000
2015-01-16 Dallas Matthew D (VP, Finance) Sale 3,075 .82 2,512
2015-01-07 Dallas Matthew D (VP, Finance) Sale 519 .80 415
2015-01-07 Vittiglio Joseph (SVP, General Counsel) Sale 4,484 .80 3,587
2015-01-07 Gyuris Jeno (SVP, Chief Scientific Officer) Sale 4,484 .80 3,587
2015-01-07 Bailey Michael P (President & CEO) Sale 4,484 .80 3,587
2014-01-30 Vittiglio Joseph (SVP, General Counsel) Sale 5,430 1.64 8,926
2014-01-30 Slichenmyer William (Chief Medical Officer) Sale 5,430 1.64 8,926
2014-01-30 Gyuris Jeno (SVP, Chief Scientific Officer) Sale 5,430 1.64 8,926
2014-01-30 Bailey Michael P (Chief Business Officer) Sale 5,430 1.64 8,926
2013-03-14 Johnston David Brannon (Chief Financial Officer) Sale 1,061 7.34 7,784
2013-03-07 Termeer Henri A (Director) Buy 55,499 6.73 373,730
2013-02-19 Young Robert C (Director) Buy 990 6.60 6,533
2013-01-28 Vittiglio Joseph (SVP & General Counsel) Sale 384 7.77 2,984
2013-01-28 Johnston David Brannon (Chief Financial Officer) Sale 1,150 7.77 8,936
2013-01-28 Ezickson Elan (Chief Operating Officer) Sale 1,150 7.77 8,936
2013-01-28 Slichenmyer William (Chief Medical Officer) Sale 1,150 7.77 8,936
2013-01-28 Gyuris Jeno (SVP, Chief Scientific Officer) Sale 767 7.77 5,960
2013-01-28 Bailey Michael P (Chief Commercial Officer) Sale 767 7.77 5,960
2012-12-13 Ha Ngoc Tuan (Chief Executive Officer) Buy 14,100 6.85 96,641
2012-12-13 Young Robert C (Director) Buy 2,371 6.78 16,068
2012-12-13 Kucherlapati Raju S (Director) Buy 15,000 6.70 100,485
2012-12-13 Termeer Henri A (Director) Buy 5,200 6.65 34,559
2012-12-12 Ha Ngoc Tuan (Chief Executive Officer) Buy 60,900 6.61 402,305
2012-12-12 Termeer Henri A (Director) Buy 39,301 6.59 258,914
2012-12-03 Young Robert C (Director) Buy 1,250 6.41 8,012
2012-09-28 Robinson Murray O. (SVP, Translational Medicine) Option Ex 37,500 2.00 75,000
2012-09-13 Johnston David Brannon (Chief Financial Officer) Sale 1,386 10.60 14,695
2012-08-08 Young Robert C (Director) Buy 1,000 8.63 8,630
2012-07-17 Slichenmyer William (Chief Medical Officer) Sale 2,000 13.17 26,332
2012-07-17 Slichenmyer William (Chief Medical Officer) Option Ex 2,000 9.64 19,280
2012-07-03 Slichenmyer William (Chief Medical Officer) Sale 1,000 13.00 13,000
2012-07-03 Slichenmyer William (Chief Medical Officer) Option Ex 1,000 9.64 9,640
2012-06-19 Slichenmyer William (Chief Medical Officer) Sale 1,000 12.00 12,000
2012-06-19 Slichenmyer William (Chief Medical Officer) Option Ex 1,000 9.64 9,640
2012-06-06 Johnston David Brannon (Chief Financial Officer) Sale 15,000 12.21 183,150
2012-06-06 Johnston David Brannon (Chief Financial Officer) Option Ex 15,000 5.60 84,000
2012-06-04 Slichenmyer William (Chief Medical Officer) Sale 1,000 13.00 13,000
2012-06-04 Slichenmyer William (Chief Medical Officer) Option Ex 1,000 9.64 9,640
2012-05-15 Slichenmyer William (Chief Medical Officer) Sale 1,000 12.42 12,420
2012-05-15 Slichenmyer William (Chief Medical Officer) Option Ex 1,000 9.64 9,640
2012-05-05 Gyuris Jeno (SVP, Chief Scientific Officer) Sale 3,000 13.17 39,501
2012-05-01 Slichenmyer William (Chief Medical Officer) Sale 1,000 12.00 12,000
2012-05-01 Slichenmyer William (Chief Medical Officer) Option Ex 1,000 9.64 9,640
2012-04-02 Slichenmyer William (Chief Medical Officer) Sale 1,000 12.38 12,377
2012-04-02 Slichenmyer William (Chief Medical Officer) Option Ex 1,000 9.64 9,640
2012-03-08 Gyuris Jeno (SVP, Chief Scientific Officer) Sale 2,000 13.06 26,130
2012-03-07 Gyuris Jeno (SVP, Chief Scientific Officer) Sale 2,000 13.00 26,000
2012-03-02 Gyuris Jeno (SVP, Chief Scientific Officer) Sale 2,100 13.16 27,636
2012-03-01 Gyuris Jeno (SVP, Chief Scientific Officer) Sale 2,000 13.33 26,660
2012-02-29 Gyuris Jeno (SVP, Chief Scientific Officer) Sale 1,000 13.18 13,175
2012-02-28 Gyuris Jeno (SVP, Chief Scientific Officer) Sale 1,000 13.08 13,080
2012-02-24 Gyuris Jeno (SVP, Chief Scientific Officer) Sale 1,500 13.68 20,524
2012-02-23 Gyuris Jeno (SVP, Chief Scientific Officer) Sale 500 13.50 6,750
2012-02-21 Slichenmyer William (Chief Medical Officer) Sale 2,000 13.66 27,330
2012-02-21 Slichenmyer William (Chief Medical Officer) Option Ex 2,000 9.64 19,280
2012-02-17 Ha Ngoc Tuan (Chief Executive Officer) Option Ex 50,000 .48 24,000
2012-02-17 Kucherlapati Raju S (Director) Buy 5,000 13.87 69,340
2012-01-26 Johnston David Brannon (Chief Financial Officer) Sale 1,107 13.37 14,796
2012-01-26 Ezickson Elan (Chief Business Officer) Sale 1,107 13.37 14,796
2012-01-26 Slichenmyer William (Chief Medical Officer) Sale 1,107 13.37 14,796
2012-01-26 Gyuris Jeno (SVP, Head of Research) Sale 738 13.37 9,864
2012-01-26 Bailey Michael P (Chief Commercial Officer) Sale 738 13.37 9,864
2012-01-26 Ha Ngoc Tuan (President & CEO) Sale 4,613 13.37 61,657
2012-01-17 Slichenmyer William (Chief Medical Officer) Sale 2,000 14.87 29,736
2012-01-17 Slichenmyer William (Chief Medical Officer) Option Ex 2,000 9.64 19,280
2011-12-23 Slichenmyer William (Chief Medical Officer) Sale 2,000 17.00 34,000
2011-12-23 Slichenmyer William (Chief Medical Officer) Option Ex 2,000 9.64 19,280
2011-12-20 Slichenmyer William (Chief Medical Officer) Sale 3,000 15.79 47,370
2011-12-20 Slichenmyer William (Chief Medical Officer) Option Ex 3,000 9.64 28,920
2011-12-01 Johnston David Brannon (Chief Financial Officer) Sale 1,000 16.74 16,737
2011-12-01 Johnston David Brannon (Chief Financial Officer) Option Ex 1,000 5.60 5,600
2011-12-01 Slichenmyer William (Chief Medical Officer) Sale 2,000 17.00 34,000
2011-12-01 Slichenmyer William (Chief Medical Officer) Option Ex 2,000 9.64 19,280
2011-11-15 Slichenmyer William (Chief Medical Officer) Sale 3,000 15.72 47,160
2011-11-15 Slichenmyer William (Chief Medical Officer) Option Ex 3,000 9.64 28,920
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of AVEO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aveo Pharmaceuticals Inc (symbol AVEO, CIK number 1325879) see the Securities and Exchange Commission (SEC) website.